7 medtech stories we missed this week: April 7, 2017
[Image from unsplash.com]New studies for umbilical cord allografts and tumor targeting were published this week while another company received European CE Marking. Here are some medtech stories we missed this week but thought were still worth mentioning. 1. AMNIOX touts new umbilical cord study AMNIOX Medical announced that it has published the results of 3 studies that demonstrate the effectiveness of umbilical cord tissue for treating chronic wounds, according to an April 7 press release. The company’s cryopreserved human umbilical cord tissue, NEOX Cord 1K was tested on 29 patients who needed a wound allograft to tr...
Source: Mass Device - April 7, 2017 Category: Medical Equipment Authors: Danielle Kirsh Tags: Clinical Trials Radiosurgery Regulatory/Compliance Research & Development Spinal Wound Care Aesculap Implant Systems Amniox AngioDynamics Cianna Medical InVivo Therapeutics MedTech Nu-Med Occlutech Source Type: news

Hodgkin Lymphoma Masquerading As Multifocal Osteomyelitis Hodgkin Lymphoma Masquerading As Multifocal Osteomyelitis
This case highlights the diagnostic challenges of an unusual presentation of Hodgkin lymphoma, leading to the misdiagnosis and treatment as chronic recurrent multifocal osteomyelitis.Journal of Medical Case Reports (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - April 7, 2017 Category: Orthopaedics Tags: Hematology-Oncology Journal Article Source Type: news

Pubic Bone Osteomyelitis and Pubosymphyseal Urinary Fistula: A Poorly Recognized Complication in Prostate Cancer Survivors
An uncommon but significantly burdensome sequela of therapy for prostate cancer is pubic bone osteomyelitis in association with a pubosymphyseal urinary fistula. (Source: CancerNetwork)
Source: CancerNetwork - March 15, 2017 Category: Cancer & Oncology Authors: Andrew C. Peterson, MD Ramiro Jose Madden-Fuentes, MD Tags: Oncology Journal Prostate Cancer Source Type: news

Fracture Healing
Fracture healing is a process in which the body heals and repairs the broken bone. Requirements for bone healing A requirement for bone healing is vascularity (sufficient blood supply). The nutrient artery supplies 80% of the cortex. The periosteal vessels supply the outer 20% of the cortex. The metaphyseal vessels provide a very rich blood supply to the ends of the bone (Figure 1). Fractures stimulate the release of growth factors that attract stem cells and promote angiogenesis, vasodilation and healing of the bone. Blood flow increases at the fracture site. Metaphyseal bone heals faster than diaphyseal bone because of...
Source: Healthy Living - The Huffington Post - January 27, 2017 Category: Consumer Health News Source Type: news

Osteomyelitis
Chronic osteomyelitis is an infection in the bone, which can be an incurable problem (Figure 1). What happens when the bone gets infection (osteomyelitis)? Usually bacteria causes infection in the bone. Leukocytes are attracted to the area and secrete enzymes in attempt to kill the bacteria (Figure 2). Leukocytes are normal white blood cells that defend the body against any outside invaders. Blood flow to the area is decreased, and devitalized necrotic bone is formed called a sequestrum (Figure 3). That sequestrum is an infected dead bone resulting from osteomyelitis. It is a nidus of infection. Haversian canals ...
Source: Healthy Living - The Huffington Post - January 27, 2017 Category: Consumer Health News Source Type: news

What is in the Differential Diagnosis of Fatigue?
Discussion Fatigue is a subjective feeling of decreased energy, tiredness or feeling of exhaustion. Lethargy is often used synonymously, but lethargy is a state of being drowsiness or sleepy, and implies mental status changes. Both can cause the person to be apathetic or less active. Fatigue is a common state that almost everyone experiences multiple times in his or her lifetime. For most people it is a relatively acute or short-term chronic problem, often with a relatively easily identifiable problem cause, such as inadequate sleep, acute illness, or overexertion. For some, it can be less readily identifiable such as dep...
Source: PediatricEducation.org - January 23, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Osteomyelitis following domestic animal bites to the hand: two case reports and practical guidelines - Lim JS, Byun JH, Min KH, Lee HK, Choi YS.
Recently, the number of cases of animal bite wounds has increased significantly in concordance with an increase in the pet population around the world. The authors report two rare cases of osteomyelitis of the phalanx following cat and dog bites. On initia... (Source: SafetyLit)
Source: SafetyLit - December 3, 2016 Category: Global & Universal Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Theravance Biopharma reports positive data from trials conducted on VIBATIV
US-based biopharmaceutical company Theravance has reported positive results from trials of VIBATIV (telavancin) in treating osteomyelitis and combat methicillin-resistant staphylococcus aureus (MRSA) pathogens. (Source: Drug Development Technology)
Source: Drug Development Technology - November 3, 2016 Category: Pharmaceuticals Source Type: news

Vertebral Osteomyelitis: Is 6 Weeks of Treatment Not Enough? Vertebral Osteomyelitis: Is 6 Weeks of Treatment Not Enough?
Paul Auwaerter is rethinking his own clinical practice for treating persistent vertebral osteomyelitis.Medscape Infectious Diseases (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - September 29, 2016 Category: Infectious Diseases Tags: Infectious Diseases Commentary Source Type: news

Bonesupport touts high infection eradication rate in prospective trial
Bonesupport today released data from the prospective trial of its Cerament G injectable antibiotic-eluting bone substitute, touting a 96% infection eradication rate in patients treated with the substitute. Data from the study was published in The Bone and Joint Journal, the company said. Cerament G is an osteoconductive, ceramic substance designed to promote bone healing while preventing bone infection, or osteomyelitis. The resorbable bone graft substitute is designed to remodel into healthy bone within 6-12 months, while preventing colonization of microorganisms by eluting the antibiotic gentamicin. “The results th...
Source: Mass Device - September 1, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Orthopedics Bonesupport Source Type: news

MassDevice.com +5 | The top 5 medtech stories for August 12, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Bonesupport wins FDA nod for Cerament G trial Bonesupport said it won an investigational device exemption for the Fortify clinical trial of its next-generation Cerament G injectable antibiotic-eluting bone substitute. Cerament ...
Source: Mass Device - August 12, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Bonesupport wins FDA nod for Cerament G trial
Bonesupport said it won an investigational device exemption for the Fortify clinical trial of its next-generation Cerament G injectable antibiotic-eluting bone substitute. Cerament G product is an osteoconductive, ceramic substance designed to promote bone healing while preventing bone infection, or osteomyelitis. The resorbable bone graft substitute is designed to remodel into healthy bone within 6-12 months, while preventing colonization of microorganisms by eluting the antibiotic gentamicin. Bonesupport said Cerament G, which won CE Mark approval in the European Union back in February 2013, is on the market in 19 co...
Source: Mass Device - August 12, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Clinical Trials Food & Drug Administration (FDA) Orthopedics Regulatory/Compliance Source Type: news

Clenched fist injury complicated by septic arthritis and osteomyelitis treated with negative pressure wound therapy: one case report - Kilian M.
We reported a 30 years old man who suffered a bite wound of the right hand in a fight. Two days after the injury, he was admitted in emergency because of stab wound above the head of the third metacarpal bone. He presented the swelling, redness, pain and f... (Source: SafetyLit)
Source: SafetyLit - June 25, 2016 Category: Global & Universal Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

ACR Appropriateness Criteria Release Expands With New, Updated Topics
Reston, VA — The American College of Radiology (ACR) released 8 new and 15 updated Appropriateness Criteria, which define national guidelines for the most appropriate medical imaging exam or radiation therapy. These continually updated criteria now include 215 topics with more than 1,080 clinical indications. “ACR Appropriateness Criteria® enhance quality of care by helping health care providers choose the most appropriate medical imaging exam, radiologic interventional procedure or radiation therapy for the patient’s condition. Such criteria use in exam ordering can improve quality, reduce unneces...
Source: American College of Radiology - May 31, 2016 Category: Radiology Source Type: news

Radiology-Guided Cultures Provide Less Invasive Osteomyelitis DiagnosisRadiology-Guided Cultures Provide Less Invasive Osteomyelitis Diagnosis
Interventional radiology-guided cultures are a less invasive alternative to operative cultures for diagnosing acute hematogenous osteomyelitis (AHO) in children, according to a retrospective review. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 11, 2016 Category: Consumer Health News Tags: Orthopaedics News Source Type: news